Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
9MW1911 in Chronic Obstructive Pulmonary Disease (COPD)
NCT07292714Phase 2Recruiting
- Sponsor
- Mabwell
- Start
- Jul 2025
- Primary completion
- Dec 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of 9MW1911 in chronic obstructive pulmonary disease (COPD), sponsored by Mabwell. Started Jul 2025; status: recruiting.
02
Drugs
9MW1911
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07292714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07292714.